Transradial approach tied to better bleeding and survival outcomes in STEMI with cardiogenic shock: Study Medha Baranwal9 May 2022 4:00 AM GMTUSA: Transradial access (TRA) in percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) with cardiogenic shock (CS)...
Age not a limiting factor- CABG Surpasses PCI for ACS in Elders with Multimorbidity MD Bureau27 April 2022 5:30 AM GMTCoronary artery disease (CAD) is a major cause of mortality and is a global health problem reaching epidemic proportions in both developed as well as...
Timely access to PCI saves lives in ACS with CS regardless of other facilities of treating hospital MD Bureau20 April 2022 4:15 AM GMTCardiogenic shock (CS) occurs in 6% to 10% of patients with acute coronary syndrome (ACS) and remains the most common cause of in-hospital mortality...
Coronary Revascularization Improves EF and reduces mortality and HF related hospitalization MD Bureau18 April 2022 5:34 PM GMTHeart failure is a major and growing public health issue worldwide. With the ageing population and advancements in medical and surgical treatments,...
FFR-guided PCI No Better Than CABG in Improving QOL: FAME 3 Trial MD Bureau16 April 2022 4:45 AM GMTIn patients with three-vessel coronary artery disease (CAD), large, randomized trials have demonstrated that coronary revascularization improves the...
Prevalence of Cardiogenic shock complicating non-ST-segment elevation doubles, reveals study MD Bureau15 Feb 2022 3:30 AM GMTCardiogenic shock (CS) complicates 5% to 10% of all acute myocardial infarctions (AMI) and remains the leading cause of death in the contemporary...
Colchicine cheap and low-risk medication to reduce MACE in patients undergoing PCI: BMJ Medha Baranwal11 Feb 2022 3:30 AM GMTUK: A recent study showed that colchicine significantly reduces MACE risk in coronary artery disease (CAD) patients who underwent percutaneous...
Revascularization with CABG tied to low MI risk than PCI in left main coronary artery disease: Lancet Medha Baranwal28 Jan 2022 3:45 AM GMTUSA: Results from a meta-analysis in The Lancet revealed no significant difference in 5-year all-cause death between patients treated with PCI versus...
One month of DAPT after PCI as good as standard therapy in those at high bleeding risk: MASTER DAPT trial Medha Baranwal14 Jan 2022 3:30 AM GMTDelhi: One month of dual antiplatelet therapy (DAPT) after the implantation of a drug-eluting coronary stent is noninferior to the continuation of...
Racial & Financial Disparities Influence Women undergoing Revascularization Post MIÂ MD Bureau13 Jan 2022 3:30 AM GMTDespite technical and pharmaceutical advancements and achievements in the last two decades and some decrease in overall mortality rate from...
QFR-guided lesion selection tied to better PCI outcomes than conventional angiography: FAVOR III China Trial Medha Baranwal10 Jan 2022 3:30 AM GMTChina: A QFR-guided strategy of lesion selection among patients undergoing percutaneous coronary intervention (PCI) improved clinical outcomes...
Amphilimus-eluting stents tied to less target lesion failure in diabetics undergoing PCI: SUGAR Trial Medha Baranwal7 Jan 2022 3:30 AM GMTSpain: Amphilimus-eluting stents (AES) are superior to zotarolimus-eluting stents (ZES) with regards to target lesion and target vessel failure...
